Technology | Wearables | August 15, 2018

iBeat Heart Watch Now Shipping

Smartwatch device continuously monitors heart and blood flow biometrics, sends alerts if events detected or patient is not responding to prompts

iBeat Heart Watch Now Shipping

August 15, 2018 — iBeat recently announced the release and shipping of its iBeat Heart Watch. The heart and blood flow monitoring smartwatch will engage the user and can notify first responders for immediate medical aid if something appears to be wrong.

The iBeat Heart Watch looks and functions like an everyday watch, but inside has an array of sensors that measure heart rate, blood flow and other biometrics. These are analyzed in real-time, leveraging artificial intelligence (AI), to look for potentially worrisome changes, such as heart rate or blood flow slowing or stopping. If something appears to be off, the watch will engage the user and ask if everything is okay. If the user confirms the need for help or does not respond, the Heart Watch will automatically connect to the iBeat’s 24-hour dispatch team, who can send the appropriate help – emergency medical services, police, firefighters, friends or family. The watch also has an emergency button that can be pressed at any time to get users emergency or non-emergency aid.

According to the Centers for Disease Control and Prevention, every 43 seconds, someone in the U.S. suffers a cardiac emergency, and emergency response time can make the difference between life and death. Because these emergencies are often unwitnessed and can happen anywhere, the iBeat Heart Watch has the potential to reduce delays in emergency response times, which could save lives and possibly prevent a user from suffering brain damage or organ failure.

Features of the iBeat Heart Watch include:

  • Continuous heart rate and blood flow monitoring – Looks for changes in real-time and alerts the user when there might be a significant or potentially serious change;
  • Dispatch and emergency contact notifications – Immediately notifies iBeat’s 24-hour dispatch team, the user’s emergency contacts, and if needed, 911;
  • Emergency help button – Can be pressed at any time to get aid from friends, family, loved ones or emergency services;
  • No smartphone or wi-fi needed – Equipped with built-in cellular functionality that can send and receive calls for help; no phone, Wi-Fi, or Bluetooth pairing is required to set up or use the watch;
  • Built-in GPS – Alerts responders and designated contacts to the user’s exact location in an emergency;
  • User dashboard – Shows overall heart health, activity levels, location and any emergency-triggered incidents; and
  • Heart Hero Network – Access to the network that makes aid available to anyone, anywhere. With more than 1 million people trained in first aid and cardiopulmonary resuscitation (CPR), the network will be automatically alerted if a nearby iBeat Heart Watch user suffers a cardiac emergency.

While the iBeat Heart Watch is intended for use as an everyday watch or for those with a heart concern, it is also an ideal replacement and upgrade from the antiquated medical alert devices currently on the market, according to the company. Most medical alert systems are pendants that brand the user as sick or elderly and require the user to stay tethered to a base station – unable to be used outside the home. They do not have the ability to measure cardiac parameters or automatically call for help. In contrast, the iBeat Heart Watch is a stylish watch that gives users the freedom to go anywhere they want, whenever they want, and keeps them within reach of immediate emergency or non-emergency aid.

iBeat is pursuing U.S. Food and Drug Administration (FDA) approval for use of its Heart Watch as a medical device and recently partnered with two of the top leading life insurers and reinsurers, Transamerica and SCOR Global Life, to extend longevity.

For more information: www.ibeat.com

Related Content

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.